SAB Biotherapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: SAB Biotherapeutics Inc: Is Infosys Ltd. worth buying?
Item: SAB Biotherapeutics Inc
Rating: 2.84433325
Author: Trendlyne DVM scores

about

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, witho...

4.01 0.03 (0.75%)

39.24% Fall from 52W High

527.4K

XNAS Volume

XNAS 20 Jan, 2026 4:30 PM (EST)

Not Eligible

Mid Valuation

41.8 / 100

Technically Bullish

71.9 / 100

No estimates available

SAB Biotherapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

SAB Biotherapeutics Inc Live Stock Price Today, Share Analysis and Chart

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, witho...

39.24% Fall from 52W High

SWOT Analysis

SAB Biotherapeutics Inc Live Price Chart